News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
270,543 Results
Type
Article (38455)
Company Profile (16)
Press Release (232067)
Multimedia
Podcasts (17)
Webinars (13)
Section
Business (71218)
Career Advice (963)
Deals (8062)
Drug Delivery (43)
Drug Development (36627)
Employer Resources (70)
FDA (6874)
Job Trends (5565)
News (124398)
Policy (12778)
Tag
Academia (2531)
Academic (1)
Accelerated approval (15)
Adcomms (17)
Allergies (61)
Alliances (15839)
ALS (83)
Alzheimer's disease (873)
Antibody-drug conjugate (ADC) (107)
Approvals (7033)
Artificial intelligence (224)
Autoimmune disease (52)
Automation (10)
Bankruptcy (151)
Best Places to Work (4915)
BIOSECURE Act (6)
Biosimilars (69)
Biotechnology (15)
Bladder cancer (86)
Brain cancer (40)
Breast cancer (358)
Cancer (2490)
Cardiovascular disease (187)
Career advice (843)
Career pathing (16)
CAR-T (132)
CDC (25)
Cell therapy (342)
Cervical cancer (19)
Clinical research (30983)
Collaboration (579)
Company closure (2)
Compensation (228)
Complete response letters (22)
COVID-19 (1823)
CRISPR (40)
C-suite (587)
Cystic fibrosis (47)
Data (3224)
Decentralized trials (1)
Denatured (6)
Depression (71)
Diabetes (211)
Diagnostics (2755)
Digital health (16)
Diversity (6)
Diversity, equity & inclusion (22)
Drug discovery (90)
Drug pricing (61)
Drug shortages (12)
Duchenne muscular dystrophy (96)
Earnings (18637)
Editorial (25)
Employer branding (4)
Employer resources (64)
Events (28964)
Executive appointments (662)
FDA (8280)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (9)
Funding (567)
Gene editing (92)
Generative AI (12)
Gene therapy (264)
GLP-1 (324)
Government (2326)
Grass and pollen (2)
Guidances (171)
Healthcare (7801)
HIV (27)
Huntington's disease (15)
IgA nephropathy (36)
Immunology and inflammation (73)
Immuno-oncology (20)
Indications (48)
Infectious disease (1970)
Inflammatory bowel disease (79)
Inflation Reduction Act (4)
Influenza (69)
Intellectual property (82)
Interviews (160)
IPO (4078)
IRA (28)
Job creations (824)
Job search strategy (710)
JPM (19)
Kidney cancer (12)
Labor market (30)
Layoffs (123)
Leadership (13)
Legal (3849)
Liver cancer (50)
Longevity (4)
Lung cancer (358)
Lymphoma (236)
Machine learning (17)
Management (26)
Manufacturing (202)
MASH (82)
Medical device (5438)
Medtech (5454)
Mergers & acquisitions (4266)
Metabolic disorders (466)
Multiple sclerosis (78)
NASH (10)
Neurodegenerative disease (158)
Neuropsychiatric disorders (26)
Neuroscience (1437)
Neurotech (1)
NextGen: Class of 2026 (2653)
Non-profit (2247)
Now hiring (10)
Obesity (166)
Opinion (135)
Ovarian cancer (96)
Pain (74)
Pancreatic cancer (107)
Parkinson's disease (112)
Partnered (8)
Patents (167)
Patient recruitment (224)
Peanut (23)
People (35601)
Pharmaceutical (1)
Pharmacy benefit managers (6)
Phase 1 (9098)
Phase 2 (13534)
Phase 3 (10757)
Pipeline (2186)
Policy (128)
Postmarket research (1447)
Preclinical (4023)
Press Release (36)
Prostate cancer (131)
Psychedelics (17)
Radiopharmaceuticals (134)
Rare diseases (376)
Real estate (1713)
Recruiting (30)
Regulatory (8623)
Reports (15)
Research institute (1635)
Resumes & cover letters (126)
Rett syndrome (10)
RNA editing (4)
RSV (28)
Schizophrenia (64)
Series A (84)
Series B (54)
Sickle cell disease (38)
Special edition (4)
Spinal muscular atrophy (59)
Sponsored (22)
Startups (1372)
Stomach cancer (6)
Supply chain (23)
Tariffs (23)
The Weekly (11)
Vaccines (585)
Venture capital (28)
Weight loss (125)
Women's health (41)
Worklife (5)
Date
Today (36)
Last 7 days (222)
Last 30 days (759)
Last 365 days (11656)
2026 (1230)
2025 (11784)
2024 (13434)
2023 (15722)
2022 (20961)
2021 (22809)
2020 (21758)
2019 (18631)
2018 (13811)
2017 (12983)
2016 (12751)
2015 (14720)
2014 (10881)
2013 (9933)
2012 (10011)
2011 (10120)
2010 (8993)
Location
Africa (447)
Alabama (20)
Alaska (3)
Arizona (99)
Arkansas (6)
Asia (16536)
Australia (3690)
California (4254)
Canada (1064)
China (439)
Colorado (161)
Connecticut (211)
Delaware (151)
Europe (41232)
Florida (557)
Georgia (149)
Idaho (26)
Illinois (347)
India (17)
Indiana (209)
Iowa (15)
Japan (201)
Kansas (32)
Kentucky (13)
Louisiana (16)
Maine (19)
Maryland (489)
Massachusetts (2839)
Michigan (88)
Minnesota (217)
Mississippi (4)
Missouri (53)
Montana (10)
Nebraska (11)
Nevada (31)
New Hampshire (30)
New Jersey (1324)
New Mexico (14)
New York (1273)
North Carolina (659)
North Dakota (4)
Northern California (2209)
Ohio (143)
Oklahoma (10)
Oregon (11)
Pennsylvania (884)
Puerto Rico (6)
Rhode Island (17)
South America (490)
South Carolina (22)
Southern California (1565)
Tennessee (62)
Texas (641)
United States (15257)
Utah (103)
Virginia (76)
Washington D.C. (25)
Washington State (414)
West Virginia (2)
Wisconsin (34)
270,543 Results for "case western reserve university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement with Case Western Reserve University
Mosaic ImmunoEngineering, Inc. announced the signing of a license agreement with Case Western Reserve University for patented technology discovered at Case Western Reserve University and Dartmouth College.
May 5, 2022
·
6 min read
PharmaTher Enters into Exclusive Option Agreement with Case Western Reserve University to Develop and Commercialize Ketamine for Rett Syndrome
PharmaTher Holdings Ltd. is pleased to announce that the Company has entered into an evaluation and exclusive option agreement with Case Western Reserve University in the development and commercialization for the intellectual property of ketamine in the treatment Rett Syndrome, a rare genetic neurological disorder.
November 1, 2022
·
6 min read
Press Releases
Neurophet Introduced Use Cases of Its AI-based Brain Imaging Analysis Solutions at the SEACURE Symposium Hosted by Nanyang Technological University in Singapore
December 10, 2025
·
3 min read
FDA
Moderna’s Outright Flu Refusal Just the Latest Case of Crossed FDA Signals
The FDA’s refusal to review Moderna’s mRNA-based flu vaccine is part of a larger communications crisis unfolding at the agency over the past nine months that has also ensnarled Sarepta, Capricor, uniQure and many more.
February 13, 2026
·
6 min read
·
Heather McKenzie
Press Releases
ProVerum Announces First Commercial Cases Completed with the ProVee® System for BPH
January 21, 2026
·
2 min read
Press Releases
Picard Medical/ SynCardia Highlights Successful Bridge-to-Transplant Case at UCSF Health Using the SynCardia Total Artificial Heart
February 12, 2026
·
4 min read
Press Releases
Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case
January 6, 2026
·
6 min read
Business
SCYNEXIS Announces $3 Million National Institutes of Health Grant Has Been Awarded to Case Western Reserve University Researchers to Study Second Generation Fungerp (SCY-247) to Fight Drug-Resistant Fungi
SCYNEXIS, Inc. today announced that researchers from Case Western Reserve University in Cleveland have been awarded a competitive research grant of more than $3 million by the National Institutes of Health (NIH), to investigate a second generation fungerp (SCY-247).
November 30, 2022
·
5 min read
Business
Forge Biologics and Case Western Reserve University Announce Gene Therapy Workforce Development Partnership
Forge Biologics and Case Western Reserve University Announce Gene Therapy Workforce Development Partnership
July 6, 2021
·
4 min read
Press Releases
Neuspera Medical Announces Milestone Case of Traditional Sacral Neuromodulation (SNM) System Removed and Replaced With the Company’s Integrated SNM System for Urinary Urge Incontinence
February 11, 2026
·
6 min read
1 of 27,055
Next
